trending Market Intelligence /marketintelligence/en/news-insights/trending/az8s8aviuaanmyzyd_tfbg2 content esgSubNav
In This List

Mylan board member to retire after 16 years

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Mylan board member to retire after 16 years

Wendy Cameron will retire from the Mylan NV board at the company's upcoming annual meeting.

Cameron served on the Pittsburgh-based pharmaceutical company's board for more than 16 years.

The board nominated Pauline van der Meer Mohr to replace Cameron as director.

Mohr is a nonexecutive director on the HSBC Holdings PLC board.